(Q43920323)

28 November 2017

title

Human placenta thioredoxin reductase: preparation and inhibitor studies (English)

1 reference

28 November 2017

4

Katja Becker

1 reference

28 November 2017

Stephan Gromer

1

1 reference

28 November 2017

Heiko Merkle

series ordinal

2

1 reference

28 November 2017

R Heiner Schirmer

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

28 November 2017

published in

Methods in Enzymology

1 reference

28 November 2017

volume

347

1 reference

28 November 2017

page(s)

382-394

1 reference

Thioredoxin reductase two modes of catalysis have evolved

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

News and views on thioredoxin reductases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Physiological functions of thioredoxin and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Thioredoxin reductase as a pathophysiological factor and drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Overexpression of wild type and SeCys/Cys mutant of human thioredoxin reductase in E. coli: the role of selenocysteine in the catalytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Preparation and assay of mammalian thioredoxin and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Reassessment of Ellman's reagent

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Glutathione reductase: solvent equilibrium and kinetic isotope effects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

The role of the C-terminus for catalysis of the large thioredoxin reductase from Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Application of a single-plasmid vector for mutagenesis and high-level expression of thioredoxin reductase and its use to examine flavin cofactor incorporation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Determination of thioredoxin reductase activity in rat liver supernatant

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Inhibition of thioredoxin reductase (E.C. 1.6.4.5.) by antitumor quinones

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Superoxide production by dinitrophenyl-derivatized thioredoxin reductase--a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Interaction of a glutathione S-conjugate with glutathione reductase. Kinetic and X-ray crystallographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Purification, crystallization and preliminary crystallographic data for rat cytosolic selenocysteine 498 to cysteine mutant thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

Microinjected glutathione reductase crystals as indicators of the redox status in living cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2947038-3

7 January 2021

10.1016/S0076-6879(02)47038-3

Identifiers

DOI

1 reference

28 November 2017

1 reference